Fare diagnosi precoce con qualche esame in più costituisce un risparmio? Sì, serve, per esempio, a prevenire gravi patologie cardiovascolari nei pazienti che soffrono di malattie autoimmuni.Il ruolo dei test per la ricerca degli Anticorpi Anti-Nucleo (ANA) e del Fattore Reumatoide (RA test ).
Referenze utili.1. Tellides G, Pober JS. Inflammatory and immune responses in the arterial mediaCirc Res. 2015 ;116:312-22.2. Ferraccioli G, Alivernini S, Tolusso B, Gremese E: Should Rheumatoid Factor(RF) and antinuclear antibodies (ANA) become routinary screening test for morbidities in the general population ? From the concept of “ bening autoimmunity” to rthe concept of “ autoimmunity as a red flag in preventive medicine “ Autoimmunity Reviews Apr.8 , S1568, 20183. Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, Visser M, Stehouwer CD, Dekker JM, Nijpels G, Heine R, Dijkmans BA, Nurmohamed MT.Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Care Res. 2009;61:1571-9.4. Koenig KF, Ribi C, Radosavac M, Zulewski H, Trendelenburg M; Swiss SLE cohort study (SSCS). Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts. Lupus. 2015;24:58-65.5. Mackey RH, Kuller LH, Deane KD, Walitt BT, Chang YF, Holers VM, Robinson WH, Tracy RP, Hlatky MA, Eaton C, Liu S, Freiberg MS, Birru Talabi M, Schelbert EB, Moreland LW. Rheumatoid arthritis, anti-CCP positivity, and cardiovascular disease risk in the Women's Health Initiative. Arthritis Rheumatol. 2015, 67: 2311-226. del Puente A, Knowler WC, Pettitt DJ, Bennett PH. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum. 1988;31:1239-44.7. Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ. 2012 Sep 6; 345:e52448. Liao KP, Gunnarsson M, Källberg H, Ding B, Plenge RM, Padyukov L, Karlson EW, Klareskog L, Askling J, Alfredsson L. Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. Arthritis Rheum. 2009;60:653-60. 9. Mantel Ä, Holmqvist M, Nyberg F, Tornling G, Frisell T, Alfredsson L, Askling J.Risk factors for the rapid risk increase of acute coronary events in patients with new-onset rheumatoid arthritis: A nested case-control study. Arthritis Rheumatol. 2015 Jul 2. 10. Tomasson G,Aspelund T, Jonsson T,Valdimarsson H, Felson DT, and Gudnason V Effect of rheumatoid factor on mortality and coronary heart disease Ann.Rheum.Dis.2010 ; 69: 1649–165411. Edwards C J, Syddall H, Goswami R, Goswami P, Dennison E M, Arden N K, C Cooper, on behalf of the Hertfordshire Cohort Study Group: The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men. Heart 2007;93:1263–1267.12. Wandstrat AE, Carr-Johnson F, Branch V, Gray H, Fairhurst AM, Reimold A, Karp D, Wakeland EK, Olsen NJ. Autoimmunity profiling to identify individuals at risk for SLE. J Autoimmun. 2006; 27:153-6013. Solow EB, Vongpatanasin W, Skaug B, Karp DR, Ayers C, de Lemos JA.Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General Population. J Am Coll Cardiol. 2015;65:2669-7014. Pertovaara M, Kahonen M, Juonala M, et al. Autoimmunity and atherosclerosis:the presence of antinuclear antibodies is associated with decreasedcarotid elasticity in young women. The Cardiovascular Risk in Young FinnsStudy. Rheumatology (Oxford) 2009;48:1553–6.15. Liang KP, Kremers HM, Crowson CS, Snyder MR, Thernau TM,Roger VL, Gabriel SE. Autoantibodies and the risk of cardiovascular events. J Rheumatol 2009;36 : 2462–9.16. McMahon M, Skaggs B. Pathogenesis and treatment of atherosclerosis in lupus.Rheum Dis Clin North Am. 2014;40:475-9517.Van Doornum S, Bohensky M, Tacey MA, Brand CA, Sundararajan V, Wicks IP.Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease. Arthritis Res Ther. 2015 ;17:3818. Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN, Dawson J, Sathi N, Ahmad Y, Koduri G, Young A; British Rheumatoid Interstitial Lung (BRILL) Network. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. Rheumatology (Oxford). 2014;53:1676-82. 19. Bauer PR, Kalra S, Osborn TG, St Sauver J, Hanson AC, Schroeder DR, Ryu JH.Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study. Respir Med. 2015;109:397-40520. Meyer-Olesen CL, Nielsen SF, Nordestgaard BG. Increased rheumatoid factor and deep venous thrombosis: 2 cohort studies of 54628 individuals from the general population. Clin Chem. 2015;61:349-59
